Home
Market Capitalization of Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd
NSE: TATVA
Market Cap
Key Highlights
- The Market Cap of Tatva Chintan Pharma Chem Ltd is ₹ 2112 crore as of 30 May 25 .
- The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 903 as of 30 May 15:30 .
- The dividend payouts of Tatva Chintan Pharma Chem Ltd changed from ₹ 2 to ₹ 2 over 3 quarters. This represents a CAGR of 0.00% .

Tatva Chintan Pharma Chem Ltd
NSE: TATVA
Share Price
Market Price of Tatva Chintan Pharma Chem Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
30 May 2025 | 903 |
29 May 2025 | 918.9 |
28 May 2025 | 883.4 |
27 May 2025 | 901.5 |
26 May 2025 | 904.4 |
23 May 2025 | 924.4 |
22 May 2025 | 920.55 |
21 May 2025 | 966.6 |
20 May 2025 | 907.9 |
19 May 2025 | 756.6 |
SWOT Analysis Of Tatva Chintan Pharma Chem Ltd
BlinkX Score for Tatva Chintan Pharma Chem Ltd
Asset Value vs Market Value of Tatva Chintan Pharma Chem Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Tatva Chintan Pharma Chem Ltd
Historical P/E Ratio of Tatva Chintan Pharma Chem Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Tatva Chintan Pharma Chem Ltd
Historical Revenue of Tatva Chintan Pharma Chem Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Tatva Chintan Pharma Chem Ltd
Historical EBITDA of Tatva Chintan Pharma Chem Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Tatva Chintan Pharma Chem Ltd
Historical Net Profit of Tatva Chintan Pharma Chem Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Tatva Chintan Pharma Chem Ltd
Historical Dividend Payouts of Tatva Chintan Pharma Chem Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Tatva Chintan Pharma Chem Ltd
About Tatva Chintan Pharma Chem Ltd
- Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
- The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
- The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
- The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), , Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).
Tatva Chintan Pharma Chem Ltd News Hub
Tatva Chintan Pharma Chem AGM scheduled
Tatva Chintan Pharma Chem announced that the Annual General Meeting (AGM) of the company will be hel
Read more
28 Aug 24
Tatva Chintan Pharma Chem to discuss results
Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 25 October
Read more
17 Oct 24
Tatva Chintan Pharma Chem reports consolidated net loss of Rs 0.66 crore in the September 2024 quarter
Net loss of Tatva Chintan Pharma Chem reported to Rs 0.66 crore in the quarter ended September 2024
Read more
25 Oct 24
Tatva Chintan Pharma Chem consolidated net profit declines 95.95% in the December 2024 quarter
Net profit of Tatva Chintan Pharma Chem declined 95.95% to Rs 0.14 crore in the quarter ended Decemb
Read more
28 Jan 25